Latest filing published 05 Jun 2026 for Anika Therapeutics, Inc., €47k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Filings by Stephen D. Griffin span 2 companies, the busiest being VSE Corp and Anika Therapeutics, Inc. The record holds 18 filings, for trades running from 9 November 2021 to 3 June 2026.
Purchases make up the whole of the open-market record (1 purchase, €128k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 11 share grants and 6 option exercises. In 2026 alone, the filings show 1 purchase and no sales.
The newest entry dates from 5 June 2026: a share grant of €47k, in Anika Therapeutics, Inc. The latest purchase dates back some time: it was published 171 days ago, on 30 April 2026. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations